The company develops and commercializes innovative biopharmaceutical solutions, specializing in advanced therapeutics and diagnostic platforms that address unmet medical needs in oncology, immunology, and rare genetic diseases. It generates revenue through multiple streams including product sales, milestone payments from licensing and partnership agreements, research collaboration fees, and royalties, leveraging proprietary technology platforms and scientific expertise to create value. The company competes by combining strong scientific talent, intellectual property, and strategic partnerships with leading institutions and pharmaceutical companies, while navigating the regulatory environment through comprehensive development programs designed to support accelerated approval pathways for novel therapeutics.